Vendor, Morrisville, NC
We Pharma, Inc.
UEI EWAMVJSFNK29, CAGE 7CN54
11 awards and $2,680,375 obligated between February 28, 2024 and July 24, 2026, 55% under full and open competition, against 2.5 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Drugs and Druggists' Sundries Merchant WholesalersNAICS 424210 | $1,980,674 |
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $699,701 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 6 |
| Competed Under SAP | 5 |
| Small Business Set Aside - Total | 1 |
| Delivery Order | 9 |
| Purchase Order | 1 |
Hear when We Pharma, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts We Pharma, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $75,000
- Soonest
- November 13, 2026
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling drugs and druggists' sundries merchant wholesalers to Food and Drug Administration, by dollars.
| DMS Pharmaceutical Group Inc.Park Ridge, IL | $677,464,718 |
| Dakota Drug, Inc.Anoka, MN | $15,378,658 |
| Mckesson CorporationIrving, TX | $13,857,213 |
| Pantherx Specialty, LLCPittsburgh, PA | $1,042,344 |
| World Bioproducts LLCWoodinville, WA | $291,117 |
| A-S Medication Solutions LLCLibertyville, IL | $235,598 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Pharmaceutical Products for CDER Research Studies - IDIQ
Food and Drug Administration, FDA Office of Acq Grant SVCS
Award noticeNAICS 325412Anywhere in the US75F40126D00023Awarded to We Pharma, Inc. for $4,000,000
Posted Sep 11
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40125F19004Delivery Order, July 28, 2025, Competed Under SAP | FDA Office of Acq Grant SVCSFood and Drug Administration | To Obtain a Reliable Source of Currently Marketed Drug Products for FDA Research Studies Supporting the Gdufa Regulatory Science Program, WiNAICS 424210, PSC Q999 | $1,507,060 |
| 75F40121F19001Delivery Order, February 28, 2024, Competed Under SAP | FDA Office of Acq Grant SVCSFood and Drug Administration | Obp IDIQ for PharmaceuticalsNAICS 424210, PSC Q999 | $500,000 |
| 75F40124F19009Delivery Order, April 25, 2024, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Task Order Against IDIQ 75F40120D00032 for Pharmaceutical Drug Products.NAICS 325412, PSC 6505 | $357,000 |
| 75F40125F19011Delivery Order, September 16, 2025, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Pharmaceutical Drug Products - to Obtain Source or Sources of Currently Marketed Drugs Products for FDA Research Studies.NAICS 325412, PSC 6505 | $300,000 |
| 75F40125F19010Delivery Order, May 14, 2025, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Pharmaceutical Drug ProductsNAICS 325412, PSC 6505 | $75,000 |
| 75F40123F19007Delivery Order, May 17, 2024, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Pharmaceutical Drug ProductsNAICS 325412, PSC 6505 | $0 |
| 75F40121D00018June 13, 2025, Competed Under SAP, 3 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | The Contractor Shall Provide the FDA with the Following: I. Products Listed in Attachment 1 (Pharmaceutical Pricing List), in Response to GoNAICS 424210, PSC Q999 | $0 |
| 75F40118P20106Purchase Order, June 24, 2025, Competed Under SAP, 2 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Pharmaceutical ProductsNAICS 325412, PSC 6505 | -$85 |
| 75F40123F19008Delivery Order, July 11, 2025, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Pharmaceutical Drug Product Orders. the Purpose of This Modification Is to De-Obligate Funds and Close Out the Contract.NAICS 325412, PSC 6505 | -$10,158 |
| 75F40121F19005Delivery Order, March 21, 2024, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | To Obtain a Reliable Source of Currently Marketed Drug Products for FDA Research Studies Supporting the Gdufa Regulatory Science Program, WiNAICS 325412, PSC 6505 | -$22,056 |
| 75F40123F19003Delivery Order, July 24, 2026, Competed Under SAP | FDA Office of Acq Grant SVCSFood and Drug Administration | Deobligation/CloseoutNAICS 424210, PSC Q999 | -$26,386 |
- Places of performance
- MarylandNorth Carolina
- Product and service codes
- Q999 Other Medical Services6505 Drugs and Biologicals
- Transactions
- 17 across 11 awards